TxFlow Level Up: trade perps and earn up to 300 USDC at $4M volume. Until Nov 2 Join
Settings8H · net · $10k
LanguageThe language of the site
ThemeDark, or a soft blue-grey
FundingPeriod funding rates are shown in
UnitsPercent or basis points
CostsCount taker fees and slippage in Net
SizePosition per leg used for Net and slippage
ExchangesWhich exchanges to include everywhere
My profile →
My profile
Backtest 30d
LegExchangePriceFund. /8hEach paymentNext inOIVol 24hLev
LONG198.11−0.0220get 0.0028% / 1h31m 11s$15K$284K10xLong Injective
SHORT198.52−0.0060pay 0.0008% / 1h31m 11s$200K$335K—Short AZverse
Price gap+0.206%
Funding gap+0.0160% /8h

Both sides work: funding pays +$5 a day on $10k, and the gap is 1.561% above its 7d average: +$156 more if it goes back.

If you open now and hold

on $10k a leg · figures of the last 7D, not a forecast
Funding−$5+0.0160% /8h now · paid −0.048% over the last 1 day (all we have)
Price+$156spread +0.206% now, avg −1.355% → +1.561% if it goes back
Costsno datano order book for AZverse
Result, before costs+$151+1.51%no pointscosts unknown: no order book for AZverse · What the last 7D really paid, hour by hour → backtest

Price and funding

1h · history
ENTRY / EXIT · 7D
Entry now—
Entry average—
Best entry—
Exit now—
Exit average—
Best exit—
Exit free—
PRICE SPREAD · 7D
Now+0.206%
Average—
Range—
Wider than now—
FUNDING SPREAD · 7D
Average /8h—
Highest—
Lowest—
Paid you—

Where the spread has been, last 7D

share of time at each level

Funding on every exchange

/8h

MRNA on 27 exchanges

lowest funding first

Before you open

3 ok · 1 to watch
  • Note: Order book unknown—
    No order-book sample for AZverse: its slippage is not counted.
  • Note: Margin at max leverage$1,000 + —
    Injective 10x, AZverse —. Keep about 2× this so a sharp move doesn’t liquidate one leg.
  • OK: Same payment interval1h / 1h
    Both legs pay at the same time.
    Next 24h at the current rates, on $10k a leg: +$4.80Long Injective: 24 payments, +$6.60; short AZverse: 24 payments, −$1.80.
  • OK: Entry gap works for you+0.206% vs −1.355%
    You short the dearer leg. If the gap goes back to average, the short gains.
  • Watch: Long leg is thinner$15K vs $200K OI
    Injective sets your exit cost. Check its book before closing.
  • Note: No points program—
    Neither exchange runs points right now.
  • OK: No KYC on either legInjective No · AZverse No
    Both exchanges let you trade without ID.

Profit calculator

both legs, in and out
Position, each leg
Hold for
Orders
Price spread
Funding rate
Funding earned−0.0108%/8h × 21 periods−$22.63
Price spread+0.206% → −1.355% (7d avg)+$156.09
Slippage, 4 ordersno data for AZverse—
Fee Injective bp × 2 orders−$0.02
Fee AZverse bp × 2 orders−$12.00
Net, fees only · 7 days · $10k+$121.44
Costs to cover0.120%Break-evenfrom the start
Slippage: Injective: live order book, 32 min ago; AZverse: no order-book sample

Cost to enter

taker + slippage from mid, one side
BUY · LONGInjective370.06doesn’t fitdoesn’t fitdoesn’t fitdoesn’t fit
SELL · SHORTAZverse—————

Closing costs about the same again.
AZverse: no data.

Alert

MRNA news

posts that mention MRNA, from every exchangeSearch all news →
10-25 09:09AZverseListingnew market mrna_usdt ($MRNA) seen by our collector
10-22 20:48ArcusOther$MRNA fell 25% today and was halted intraday on its primary exchange. The MRNA perp on Arcus kept trading through the halt. Traders could open, reduce, or close positions the entire time - as there is no halt state on Arcus perps. Markets run 24/7. Read more about Arcus RWA Perps here: @arcus_xyz on X ↗
10-22 19:35PhoenixOtherModerna falls after reported leak of Phase 3 melanoma vaccine data showing a 42% cut in recurrence risk, below Phase 2's 49%. $MRNA is trading at $195 on Phoenix, 24/7. @PhoenixTrade on X ↗
10-22 19:27BitgetOtherStay on top of fast-moving stock markets with Bitget Stock Perps. 📈📉 Here's the latest on Moderna $MRNA today ⤵️ @bitget on X ↗
10-20 17:07PhoenixOtherJUST IN: Moderna $MRNA is still climbing, up nearly 7% in the last 24 hours ahead of Saturday's Phase 3 cancer vaccine data at ESMO. @PhoenixTrade on X ↗
10-19 13:46PhoenixOtherJUST IN: $MRNA jumps 8.45% in anticipation of their Stage 3 cancer vaccine clinical trial results releasing on October 24. @PhoenixTrade on X ↗